FDA Clearance Tracker · P100010-S110
Arctic Front Advance and Arctic Front Advance Pro Cryoablation Catheter
Last checked: Nov 20, 2026Latest source record: Jun 18, 2021 (this decision)Source: openFDAMethods & limitations
Decided
Jun 18, 2021
Approved
Time to decision
231 days
Received Oct 30, 2020. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Panel Track
Device class
Class III
The decision
- FDA number
- P100010-S110
- Device name
- Arctic Front Advance and Arctic Front Advance Pro Cryoablation Catheter
- Applicant
- Medtronic Cryocath, LP
- Applicant location
- Mounds View, MN
- Received
- Oct 30, 2020
- Decided
- Jun 18, 2021
- Decision
- Approved
- Supplement type
- Panel Track
- Reason for supplement
- Labeling Change - Indications/instructions/shelf life/tradename
- Original approval
- P100010
Device type
- Device class
- Class III
- Specialty
- CardiologyElectrophysiology
FDA's approval statement
As written in FDA's record.
Approval for expanding the indications to include the treatment of recurrent symptomatic paroxysmal atrial fibrillation as an alternative to antiarrhythmic drug therapy as an initial rhythm control strategy.
Source documents
Other decisions for Medtronic Cryocath, LP
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K202620 · Decided Nov 13, 2020 · 64 days after receipt
Device type: Catheter, Steerable (DRA) · Cardiology
4 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.